Effects of a meal and its composition on the bioavailability of betaxolol administered orally to healthy subjects. - Suppr | 超能文献

Effects of a meal and its composition on the bioavailability of betaxolol administered orally to healthy subjects.

作者信息

Thiercelin J F, Bianchetti G, Larribaud J, Ganansia J, Deves C, Trocherie S, Abriol C, Morselli P L

出版信息

World Rev Nutr Diet. 1984;43:183-6. doi: 10.1159/000409071.

DOI:10.1159/000409071

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Effects of a meal and its composition on the bioavailability of betaxolol administered orally to healthy subjects.

World Rev Nutr Diet. 1984;43:183-6. doi: 10.1159/000409071.

2

Pharmacokinetics of betaxolol in middle aged patients.倍他洛尔在中年患者中的药代动力学

Eur J Clin Pharmacol. 1986;31(2):231-3. doi: 10.1007/BF00606665.

3

Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.新型β-肾上腺素能受体阻滞剂倍他洛尔（SL 75212）多次口服给药后在人体的药代动力学

Arzneimittelforschung. 1980;30(11):1912-6.

4

Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.新型β-肾上腺素能受体拮抗剂倍他洛尔（SL 75212）口服和静脉给药后的血药浓度及药效学效应

Br J Clin Pharmacol. 1980 Nov;10(5):449-52. doi: 10.1111/j.1365-2125.1980.tb01787.x.

5

Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.比索洛尔（一种新型高β1选择性肾上腺素能受体拮抗剂）的基础药代动力学

J Clin Pharmacol. 1986 Nov-Dec;26(8):616-21. doi: 10.1002/j.1552-4604.1986.tb02959.x.

6

Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjects.倍他洛尔在正常健康受试者中的绝对生物利用度和剂量比例性。

J Pharm Sci. 1988 Sep;77(9):779-83. doi: 10.1002/jps.2600770913.

7

Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].

Br J Clin Pharmacol. 1979 Oct;8(4):408P. doi: 10.1111/j.1365-2125.1979.tb04755.x.

8

[The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].[1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁氨基丙烷（他林洛尔，Cordanum，02-115）的药代动力学 2. 大鼠体内14C标记化合物的排泄、血药浓度及分布]

Pharmazie. 1975 Oct;30(10):675-7.

9

Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.新型β-肾上腺素能受体阻滞剂卡替洛尔的药代动力学及绝对生物利用度

Eur J Clin Pharmacol. 1983;25(1):95-101. doi: 10.1007/BF00544023.

10

Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings].

Br J Clin Pharmacol. 1980 Mar;9(3):299P.

引用本文的文献

1

Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.倍他洛尔。对其药效学、药代动力学特性及在高血压治疗中的疗效的综述。

Drugs. 1986 Jan;31(1):6-28. doi: 10.2165/00003495-198631010-00002.

2

Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.眼部用倍他洛尔。对其药理特性以及在青光眼和高眼压症中的治疗效果的综述。

Drugs. 1990 Jul;40(1):75-90. doi: 10.2165/00003495-199040010-00005.